SFRP1 and obesity disorder: In a recent study, Wang et al. demonstrated that GSK3 is essential to adipocyte differentiation and that the obesity-induced increase of Sfrp1 expression can be reversed by GSK3 inhibitors [40], further supporting the notion that GSK3 is involved in obesity.